- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-12-21
DOI
10.3389/fimmu.2020.601497
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Situ Photocatalysis of TiO-porphyrin Encapsulated Nanosystem for Highly Efficient Oxidative Damage against Hypoxic Tumors
- (2020) Huaqing Chen et al. ACS Applied Materials & Interfaces
- First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors
- (2020) Mikiya Ishihara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Self-Assembled Nanoparticles Prepared from Low-Molecular-Weight PEI and Low-Generation PAMAM for EGFRvIII-Chimeric Antigen Receptor Gene Loading and T-Cell Transient Modification
- (2020) Qianru Yu et al. International Journal of Nanomedicine
- Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment
- (2020) Dan Guo et al. International Journal of Nanomedicine
- Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
- (2020) Margaret M. Billingsley et al. NANO LETTERS
- Combining microenvironment normalization strategies to improve cancer immunotherapy
- (2020) Fotios Mpekris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-EGFR-Coated Gold Nanoparticles In Vitro Carry 5-Fluorouracil to Colorectal Cancer Cells
- (2020) Raquel B. Liszbinski et al. Materials
- Remodeling of Metastatic Vasculature Reduces Lung Colonization and Sensitizes Overt Metastases to Immunotherapy
- (2020) Bo He et al. Cell Reports
- Reshaping Tumor Immune Microenvironment through Acidity-Responsive Nanoparticles Featured with CRISPR/Cas9-Mediated Programmed Death-Ligand 1 Attenuation and Chemotherapeutics-Induced Immunogenic Cell Death
- (2020) Kun Tu et al. ACS Applied Materials & Interfaces
- Phase 2 study of hyper‐CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia
- (2020) Koji Sasaki et al. AMERICAN JOURNAL OF HEMATOLOGY
- Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer
- (2020) Marcus Ruscetti et al. CELL
- Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma
- (2020) Yu Hei et al. International Journal of Nanomedicine
- Nanoparticle interactions with immune cells dominate tumor retention and induce T cell–mediated tumor suppression in models of breast cancer
- (2020) Preethi Korangath et al. Science Advances
- Recent Progress on the Versatility of Virus-Like Particles
- (2020) Ciying Qian et al. Vaccines
- Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy
- (2020) Waqas Nawaz et al. Acta Biomaterialia
- Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
- (2020) Jesús Zepeda-Cervantes et al. Frontiers in Immunology
- Self-Assembled Multivalent Aptamer Nanoparticles with Potential CAR-like Characteristics Could Activate T Cells and Inhibit Melanoma Growth
- (2020) Chenjun Bai et al. Molecular Therapy-Oncolytics
- Fucoidan-based, tumor-activated nanoplatform for overcoming hypoxia and enhancing photodynamic therapy and antitumor immunity
- (2020) Chu-Hung Chung et al. BIOMATERIALS
- High-affinity mutant Interleukin-13 targeted CAR T cells enhance delivery of clickable biodegradable fluorescent nanoparticles to glioblastoma
- (2020) Gloria B. Kim et al. Bioactive Materials
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Antibody-based nanotechnology
- (2019) Yaron Hillman et al. NANOTECHNOLOGY
- Surface functionalized folate targeted oleuropein nano-liposomes for prostate tumor targeting: In vitro and in vivo activity
- (2019) Anmar M. Nassir et al. LIFE SCIENCES
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2019) Miguel F. Sanmamed et al. CELL
- Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells
- (2019) Qian Chen et al. ADVANCED MATERIALS
- An Oxygen Self-sufficient Fluorinated Nanoplatform for Relieved Tumor Hypoxia and Enhanced Photodynamic Therapy of Cancers
- (2019) Shengnan Ma et al. ACS Applied Materials & Interfaces
- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
- (2019) Leonie Voorwerk et al. NATURE MEDICINE
- Targeted antibody and cytokine cancer immunotherapies through collagen affinity
- (2019) Jun Ishihara et al. Science Translational Medicine
- Nanoparticles from Cuttlefish Ink Inhibit Tumor Growth by Synergizing Immunotherapy and Photothermal Therapy
- (2019) Rong-Hui Deng et al. ACS Nano
- Tumor-specific delivery of gemcitabine with activatable liposomes
- (2019) Samantha T. Tucci et al. JOURNAL OF CONTROLLED RELEASE
- Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
- (2019) Thomas Yau et al. JOURNAL OF HEPATOLOGY
- Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
- (2019) Paolo Antonio Ascierto et al. NATURE MEDICINE
- Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
- (2019) Antoni Ribas et al. NATURE MEDICINE
- Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities
- (2019) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- Near-Infrared II Phototherapy Induces Deep Tissue Immunogenic Cell Death and Potentiates Cancer Immunotherapy
- (2019) Yinchu Ma et al. ACS Nano
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
- (2019) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
- (2019) Hannah Onafuye et al. Beilstein Journal of Nanotechnology
- Dopamine Delivery via pH‐Sensitive Nanoparticles for Tumor Blood Vessel Normalization and an Improved Effect of Cancer Chemotherapeutic Drugs
- (2019) Mohammad Taleb et al. Advanced Healthcare Materials
- Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
- (2019) Muhammad Zaeem Noman et al. Cells
- Herceptin-conjugated paclitaxel loaded PCL-PEG worm-like nanocrystal micelles for the combinatorial treatment of HER2-positive breast cancer
- (2019) Jiahui Peng et al. BIOMATERIALS
- T cell immunotherapy enhanced by designer biomaterials
- (2019) Zachary S. Dunn et al. BIOMATERIALS
- Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial
- (2019) Farastuk Bozorgmehr et al. BMC CANCER
- Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells
- (2019) Jay Friedman et al. CLINICAL CANCER RESEARCH
- CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice
- (2019) Laboni Mondal et al. International Journal of Nanomedicine
- Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy
- (2019) Xiaojing Shi et al. MOLECULAR THERAPY
- Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies
- (2019) Yun-Chieh Sung et al. Nature Nanotechnology
- Immune Checkpoint Blockade Mediated by a Small‐Molecule Nanoinhibitor Targeting the PD‐1/PD‐L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer
- (2019) Rui Zhang et al. Small
- Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combination
- (2019) Yosi Gilad et al. Scientific Reports
- Engineered nano-immunopotentiators efficiently promote cancer immunotherapy for inhibiting and preventing lung metastasis of melanoma
- (2019) Lijia Luo et al. BIOMATERIALS
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanoparticles-mediated reoxygenation strategy relieves tumor hypoxia for enhanced cancer therapy
- (2019) Hong Wang et al. JOURNAL OF CONTROLLED RELEASE
- Measurement of NLG207 (formerly CRLX101) nanoparticle-bound and released camptothecin in human plasma
- (2019) Keith T. Schmidt et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Normalizing Tumor Microenvironment Based on Photosynthetic Abiotic/Biotic Nanoparticles
- (2018) Diwei Zheng et al. ACS Nano
- A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy
- (2018) Yu Mi et al. ADVANCED MATERIALS
- Delivery of small interfering RNA against Nogo-B receptor via tumor-acidity responsive nanoparticles for tumor vessel normalization and metastasis suppression
- (2018) Bin Wang et al. BIOMATERIALS
- Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors
- (2018) Hyesun Hyun et al. BIOMATERIALS
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
- (2018) Kristian M. Hargadon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Maturation of dendritic cells in vitro and immunological enhancement of mice in vivo by pachyman- and/or OVA-encapsulated poly(D,L-lactic acid) nanospheres
- (2018) Sisi Zheng et al. International Journal of Nanomedicine
- Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells
- (2018) Heng Dong et al. International Journal of Nanomedicine
- Leakage kinetics of the liposomal chemotherapeutic agent Doxil: The role of dissolution, protonation, and passive transport, and implications for mechanism of action
- (2018) Luisa M. Russell et al. JOURNAL OF CONTROLLED RELEASE
- Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy
- (2018) Chih-Sheng Chiang et al. Nature Nanotechnology
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole
- (2018) P. A. Pacheco et al. PARASITOLOGY RESEARCH
- Complete Local and Abscopal Responses from a Combination of Radiation and Nivolumab in Refractory Hodgkin's Lymphoma
- (2018) Qian Qin et al. RADIATION RESEARCH
- Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
- (2018) Wantong Song et al. Nature Communications
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
- (2018) Ferdinandos Skoulidis et al. Cancer Discovery
- Oxygen-generating Hybrid Polymeric Nanoparticles with Encapsulated Doxorubicin and Chlorin e6 for Trimodal Imaging-Guided Combined Chemo-Photodynamic Therapy
- (2018) DanRong Hu et al. Theranostics
- Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al2O3 nanoparticles
- (2018) Wenfei Chen et al. Theranostics
- CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T-cell Hypofunction
- (2018) Natnaree Siriwon et al. Cancer Immunology Research
- Identifying and managing the adverse effects of immune checkpoint blockade
- (2018) Arthur Winer et al. Journal of Thoracic Disease
- Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy
- (2018) Jinrong Peng et al. Advanced Science
- Tumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition via a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation Therapy and Abscopal Effects
- (2018) Lingtong Meng et al. ACS Nano
- Harnessing albumin as a carrier for cancer therapies
- (2018) Ella N. Hoogenboezem et al. ADVANCED DRUG DELIVERY REVIEWS
- Gold nanoparticles-mediated photothermal therapy and immunotherapy
- (2018) Yang Liu et al. Immunotherapy
- Immune-related adverse events from combination immunotherapy in cancer patients: A comprehensive meta-analysis of randomized controlled trials
- (2018) Bo Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Porous Gold Nanoshells on Functional NH2 -MOFs: Facile Synthesis and Designable Platforms for Cancer Multiple Therapy
- (2018) Chuang Liu et al. Small
- Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles
- (2018) Zaigang Zhou et al. Theranostics
- Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
- (2018) Sandro Matosevic Journal of Immunology Research
- High-Dose Vincristine Sulfate Liposome Injection, for Advanced, Relapsed, or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial
- (2018) Gary J. Schiller et al. Journal of Adolescent and Young Adult Oncology
- A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma
- (2018) Jennifer L. McQuade et al. BMC CANCER
- A new drug carrier with oxygen generation function for modulating tumor hypoxia microenvironment in cancer chemotherapy
- (2018) Zhe Zhang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Virus-Like Particles as Carrier Systems to Enhance Immunomodulation in Allergen Immunotherapy
- (2018) Martina Anzaghe et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
- (2018) Kaitlin Graham et al. International Journal of Nanomedicine
- Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
- (2018) Priyamvada Jayaprakash et al. JOURNAL OF CLINICAL INVESTIGATION
- Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
- (2018) Frank Stephen Hodi et al. LANCET ONCOLOGY
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Perfluorocarbon Nanoparticles Mediated Platelet Blocking Disrupt Vascular Barriers to Improve the Efficacy of Oxygen-Sensitive Antitumor Drugs
- (2018) Zaigang Zhou et al. Small
- Gold nanoparticles attenuate metastasis by tumor vasculature normalization and epithelial–mesenchymal transition inhibition
- (2017) Wei Li et al. International Journal of Nanomedicine
- Simple nanoliposomes encapsulating Lycium barbarum polysaccharides as adjuvants improve humoral and cellular immunity in mice
- (2017) Ruonan Bo et al. International Journal of Nanomedicine
- Modulating tumor hypoxia by nanomedicine for effective cancer therapy
- (2017) Rana Jahanban-Esfahlan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
- (2017) Jacob Schachter et al. LANCET
- Supportive care for patients undergoing immunotherapy
- (2017) Bernardo Leon Rapoport et al. SUPPORTIVE CARE IN CANCER
- Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers
- (2017) H. F. Moffett et al. Nature Communications
- Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
- (2017) Guizhi Zhu et al. Nature Communications
- Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles
- (2016) Sin-Tzu Ning et al. ACS Applied Materials & Interfaces
- Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy
- (2016) Panpan Zhang et al. CANCER SCIENCE
- Management of toxicities of immune checkpoint inhibitors
- (2016) Lavinia Spain et al. CANCER TREATMENT REVIEWS
- Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment
- (2016) Jeremiah L. Oyer et al. CYTOTHERAPY
- The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy
- (2016) Frank C. Passero et al. Expert Review of Anticancer Therapy
- Photo-thermal therapy of bladder cancer with Anti-EGFR antibody conjugated gold nanoparticles
- (2016) Chieh Hsiao Chen Frontiers in Bioscience-Landmark
- PEG- b -PLA micelles and PLGA- b -PEG- b -PLGA sol–gels for drug delivery
- (2016) Hyunah Cho et al. JOURNAL OF CONTROLLED RELEASE
- Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
- (2016) Corey J Langer et al. LANCET ONCOLOGY
- Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer
- (2016) Paul E. Hughes et al. TRENDS IN IMMUNOLOGY
- Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine
- (2016) David B. Page et al. Journal for ImmunoTherapy of Cancer
- Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
- (2016) Takashi Nakamura et al. Scientific Reports
- Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy
- (2015) Karlo Perica et al. ACS Nano
- Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
- (2015) L. Apetoh et al. ANNALS OF ONCOLOGY
- Initial Evaluation of the Safety of Nanoshell-Directed Photothermal Therapy in the Treatment of Prostate Disease
- (2015) Joshua M. Stern et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer
- (2015) Seong Ho Choi et al. JOURNAL OF CONTROLLED RELEASE
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian Cancer Immunotherapy Using PD-L1 siRNA Targeted Delivery from Folic Acid-Functionalized Polyethylenimine: Strategies to Enhance T Cell Killing
- (2015) Pei Yun Teo et al. Advanced Healthcare Materials
- Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory t cells
- (2014) Wei Ye et al. Journal of Translational Medicine
- Effect of nanovaccine chemistry on humoral immune response kinetics and maturation
- (2014) Shannon L. Haughney et al. Nanoscale
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
- (2014) F. S. Hodi et al. Cancer Immunology Research
- Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
- (2014) L. Jeanbart et al. Cancer Immunology Research
- In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes
- (2013) Yiran Zheng et al. JOURNAL OF CONTROLLED RELEASE
- Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
- (2012) Christoph Mamot et al. LANCET ONCOLOGY
- Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape
- (2012) Salem Chouaib et al. Frontiers in Immunology
- Autophagy-assisted antigen cross-presentation
- (2012) Yongxiang Yi et al. OncoImmunology
- Molecular Pathways: Hypoxia Response in Immune Cells Fighting or Promoting Cancer
- (2011) Asis Palazón et al. CLINICAL CANCER RESEARCH
- Antiangiogenic properties of silver nanoparticles
- (2009) Sangiliyandi Gurunathan et al. BIOMATERIALS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now